Ouabain augments Ca(2+) transients in arterial smooth muscle without raising cytosolic Na(+)

Am J Physiol Heart Circ Physiol. 2000 Aug;279(2):H679-91. doi: 10.1152/ajpheart.2000.279.2.H679.

Abstract

Ouabain and other cardiotonic steroids (CTS) inhibit Na(+) pumps and are widely believed to exert their cardiovascular effects by raising the cytosolic Na(+) concentration ([Na(+)](cyt)) and Ca(2+). This view has not been rigorously reexamined despite evidence that low-dose CTS may act without elevating [Na(+)](cyt); also, it does not explain the presence of multiple, functionally distinct isoforms of the Na(+) pump in many cells. We investigated the effects of Na(+) pump inhibition on [Na(+)](cyt) (with Na(+) binding benzofuran isophthalate) and Ca(2+) transients (with fura 2) in primary cultured arterial myocytes. Low concentrations of ouabain (3-100 nM) or human ouabain-like compound or reduced extracellular K(+) augmented hormone-evoked mobilization of stored Ca(2+) but did not increase bulk [Na(+)](cyt). Augmentation depended directly on external Na(+), but not external Ca(2+), and was inhibited by 10 mM Mg(2+) or 10 microM La(3+). Evoked Ca(2+) transients in pressurized small resistance arteries were also augmented by nanomolar ouabain and inhibited by Mg(2+). These results suggest that Na(+) enters a tiny cytosolic space between the plasmalemma (PL) and the adjacent sarcoplasmic reticulum (SR) via an Mg(2+)- and La(3+)-blockable mechanism that is activated by SR store depletion. The Na(+) and Ca(2+) concentrations within this space may be controlled by clusters of high ouabain affinity (alpha3) Na(+) pumps and Na/Ca exchangers located in PL microdomains overlying the SR. Inhibition of the alpha3 pumps by low-dose ouabain should raise the local concentrations of Na(+) and Ca(2+) and augment hormone-evoked release of Ca(2+) from SR stores. Thus the clustering of small numbers of specific PL ion transporters adjacent to the SR can regulate global Ca(2+) signaling. This mechanism may affect vascular tone and blood flow and may also influence Ca(2+) signaling in many other types of cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arginine Vasopressin / pharmacology
  • Biological Factors / pharmacology
  • Calcium / metabolism*
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology*
  • Cardenolides
  • Cardiotonic Agents / pharmacology
  • Cells, Cultured
  • Cytosol / metabolism
  • Digoxin*
  • Humans
  • Kinetics
  • Mesenteric Arteries / cytology
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / physiology*
  • Models, Cardiovascular
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology*
  • Ouabain / pharmacology*
  • Phenylephrine / pharmacology
  • Potassium / pharmacology
  • Rats
  • Saponins*
  • Serotonin / pharmacology
  • Sodium / metabolism*
  • Tetrodotoxin / pharmacology

Substances

  • Biological Factors
  • Cardenolides
  • Cardiotonic Agents
  • Saponins
  • digoxin-like factors
  • Arginine Vasopressin
  • Phenylephrine
  • Serotonin
  • Tetrodotoxin
  • Ouabain
  • Digoxin
  • Sodium
  • Potassium
  • Calcium